All data are based on the daily closing price as of April 1, 2025
m
Microbio
4128.TWO
0.81 USD
0.03
+3.85%
Overview
Last close
0.81 usd
Market cap
479.22M usd
52 week high
1.69 usd
52 week low
0.78 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
9.4225
Price/Book Value
1.4839
Enterprise Value
401.74M usd
EV/Revenue
7.7417
EV/EBITDA
-10.9139
Key financials
Revenue TTM
51.89M usd
Gross Profit TTM
20.36M usd
EBITDA TTM
-10.55M usd
Earnings per Share
-0.06 usd
Dividend
N/A usd
Total assets
424.77M usd
Net debt
N/A usd
About
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei City, Taiwan.